Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
about
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccineRubella vaccination in the puerperium.Rubella screening and immunization of schoolgirls: a long-term evaluation.A field with a liver measles-mumps-rubella vaccine.Clinical and laboratory studies with rubella vaccines in adults.Rubella vaccine trial in children.
P2860
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@en
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@nl
type
label
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@en
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@nl
prefLabel
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@en
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@nl
P2093
P1476
Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
@en
P2093
Huggelen C
Peetermans J
P304
P356
10.1001/ARCHPEDI.1968.02100010660004
P577
1968-06-01T00:00:00Z